본문바로가기
Language
Q
U
I
C
K

ESG

SK bioscience is committed to establishing a corporate culture
and system for sustainable product development.

Board of Directors

Composition of the board of directors

The board of directors (“BOD”) consists of 2 executive directors, 4 outside directors and 1 non-executive director, a total of 7 members.

이사회의 구성에 관한 사항 - 인원, 사내이사(2명), 사외이사(3명), 기타비상무이사(1명) 비고 정보제공
Members 2 executive directors 4 outside directors 1 Non-executive director Remarks
7 members Jae-Yong Ahn, Hoon Kim Ik-Hwan Kwon Chang-Jin Moon, Mi-Jin Jo, Jeong-Wook Choi Kwang-Hyun Jun Audit Committee (3 outside directors)

Executive directors

대표이사 안재용 사진
CEO Jae-Yong Ahn the current President and CEO of SK bioscience

Appointed on: March 2021 / End of term: March 2024

  • (Former) Managing director of VAX Division, SK Chemicals
  • (Former) Head of LS Strategic Planning, SK Chemicals and Head of Business Management, SK Gas
  • Bachelor of economics, Yonsei University / University of Chicago (MBA)
CTO 김훈 사진
CTO Hoon Kim the current CTO of SK bioscience

Appointed on: March 2021 / End of term: March 2024

  • (Former) CTO of VAX Division and Head of VAX Division, SK Chemicals
  • (Former) Researcher at Vaccine Research Group, GC Pharma
  • Ph.D. in molecular science, Korea University / Master degree in biochemistry, Korea University / Bachelor of agricultural chemistry, Korea University

Outside directors

사외이사 권익환 사진
Ik-Hwan Kwon

Appointed on: March 2021 / End of term: March 2024

  • (Current) Attorney at Kwon Ik-Hwan Law Firm
  • (Former) Prosecutor at Seoul Southern District Prosecutors' Office
  • (Former) Chief of Public Security Department, Supreme Prosecutors' Office
  • Bachelor of law, Seoul National University
사외이사 문창진 사진
Chang-Jin Moon

Appointed on: October 2020 / End of term: March 2023

  • (Former) Vice President of CHA University
  • (Former) Chairperson of the BOD, Korea Health Promotion Institute
  • (Former) Vice Minister of Health and Welfare of Korea
  • Ph.D. and Master degree in sociology, the University of Chicago / Bachelor of sociology, Seoul National University
사외이사 조미진 사진
Mi-Jin Jo

Appointed on: October 2020 / End of term: March 2023

  • (Current) Future Captiva Leadership Group President & CEO
  • (Former) Vice President of Human Resources Development Center, Hyundai Motor Group
  • (Former) Head of Human Resources Development Center, LG Display (CHRO)
  • Master degree in educational engineering, Indiana University / Bachelor of sociology, Yonsei University
사외이사 최정욱 사진
Jeong-Wook Choi

Appointed on: October 2020 / End of term: March 2023

  • (Former) Head of Tax and Accounting, Jipyeong Law Firm
  • (Former) Leader of Tax Division, Samjong KPMG
  • (Former) Manager in Tax Department, Kim & Chang Law Firm
  • Ph.D. in accounting, the University of Texas at Austin / Master degree in business, Seoul National University / Bachelor of sociology, Seoul National University /
    Ph.D. in business, Gachon University / Ph.D. in North Korean studies, the University of North Korean Studies

Non-executive directors

기타비상무이사 전광현 사진
Kwang-Hyun Jun

Appointed on: March 2022 / End of term: March 2025

  • (Current) President and CEO of SK Chemical, Representative of Pharma division, President of SK Plasma
  • (Current) President of SK bioscience
  • (Former) President/CEO and GC Biz. COO of SK chemical LS Biz.
  • Bachelor of business, Korea University
01 Authority of the Board of Directors

The board of directors shall draw resolutions on matters stipulated in laws or the articles of incorporation, matters delegated by the general meeting of shareholders, and important matters related to the company’s business execution and supervise the execution of duties of directors.

이사회의 권한 내용 - 구분, 주요내용 정보제공
Category Description
Article 3 (Composition and Authority)
  • The board of directors shall be exclusively composed of directors.
  • The board of directors shall decide on matters stipulated in laws or articles of incorporation, matters delegated by the general meeting of shareholders, and important matters related to the Company’s basic management policy and its business execution.
  • The board of directors shall supervise the execution of the duties of the directors.
Article 11 (BOD Agenda)

The matters to be brought to the Board of Directors are as follows.

1. Matters related to the general meeting of shareholders
  • A. Convocation of a general meeting of shareholders
  • B. Approval of financial statements and business reports
  • C. Change of articles of incorporation
  • D. Appointment and dismissal of directors
  • E. Appointment and dismissal of audit committee members
  • F. Determination of the limit of remuneration for directors
  • G. Decrease in capital
  • H. Comprehensive stock exchange/transfer, relocation, disbandment, merger, spin-off, spin-off merger, and continuation of the Company
  • I. Transfer, acquisition, lease of business
    • (1) Transfer of all or an important part of business
    • (2) Lease of, or entrustment of the entire business and conclusion, change, or cancellation of a contract that shares all profits and losses of business with other parties
    • (3) Acquisition of the entire business from other companies
    • (4) Acquisition of part of the business of other companies that will significantly affect the business of the acquiring company
  • J. Issuance of shares, below par
  • K. Merger of stocks
  • L. Stock split
  • M. Other agenda items to be referred to the general meeting of shareholders
2. Management matters
  • A. Appointment and dismissal of managers
  • B. Establishment, relocation, and abolition of branches
  • C. Closing of the shareholder register and determination of the base day
  • D. Enactment and closing of BOD regulations
  • E. Enactment and closing of internal accounting management regulations
  • F. New construction and expansion of production facilities and R&D investment of more than 2% of equity capital, as of the present time (end of the latest business year)
  • G. Development and revision of practical strategies to implement the management philosophy pursuant to Article 3-3 of this regulation
  • H. Donations of over KRW 1 billion However, emergency relief for natural disasters such as typhoons, floods, fires, and earthquakes and donations per the Common Chest of Social Welfare Act can be reported after execution.
  • I. The Company's safety and health plan as approved by the board of directors in the Occupational Safety and Health Act
  • J. Determination of other major matters related to the management of the company and the changes to such determinations
3. Financial matters
  • A. Issuance of new shares
  • B. Capitalization of reserve
  • C. Issuance of corporate bonds
  • D. Designation and change of transfer agent
  • E. Issuance of convertible bonds and warrant bonds
  • F. The following debt burden, asset acquisition, and disposal of more than 2% of equity capital, as of the present time (end of the latest business year)
    • (1) Borrowing of new funds for more than one year
    • (2) Provision of collateral and guarantee of debt
    • (3) Investment and rental by other corporations
    • (4) Acquisition and disposal of assets
4. Matters related to manpower and organizational management
  • A. Appointment of CEO
  • B. The authority of the director to chair the general meeting of shareholders and the board of directors in the event that the CEO or the representative director is unable to perform his/her duties
  • C. Appointment of chairperson of the board of directors
  • D. Approval of competitive transaction of directors
  • E. Approval of transactions between directors, etc. and the Company, as stipulated in Article 398 of the Commercial Act
  • F. Cancellation of stock options and employee ownership stock options
  • G. Adoption of a relief system for executives' liability insurance and other executives' responsibilities
  • H. Approval for transactions on directors own account in contravention, etc., as stipulated in Article 397-2 of the Commercial Act
  • I. Composition, establishment and operation of BOD committees and appointment and dismissal of members of each committee except for the audit committee
  • J. Appointment and dismissal of compliance officers and establishment and revision of compliance control standards
5. Other matters stipulated in laws or the articles of incorporation, matters delegated by the general meeting of shareholders, and matters deemed necessary by the CEO
02 Disclosure of the personal information of the director candidates to the general meeting of shareholders and the recommendations by shareholders

Our company has no history of such disclosure and no candidates recommended by shareholders.

03 Establishment and composition of the Outside Director Candidate Recommendation Committee
사외이사후보추천위원회 설치 및 구성 현황 - 성명, 사외이사 여부, 주요내용 정보제공
Name Qualification for Outside Director Remarks
Ik-Hwan Kwon Y Awarded a majority vote with all registered members attended as pursuant to Article 8, Paragraph 1 of the Regulations of the Outside Director Candidate Recommendation Committee
Chang-Jin Moon Y Awarded a majority vote with all registered members attended as pursuant to Article 8, Paragraph 1 of the Regulations of the Outside Director Candidate Recommendation Committee
Mi-Jin Jo Y Awarded a majority vote with all registered members attended as pursuant to Article 8, Paragraph 1 of the Regulations of the Outside Director Candidate Recommendation Committee

Matters concerning the operation of the BOD

01 Key provisions of the BOD regulations
이사회 운영규정의 주요내용 - 조항, 상세내용 정보제공
Article Description
Article 3 (Composition and Authority)
  • The board of directors shall be exclusively composed of directors.
  • The board of directors shall decide on matters stipulated in laws or articles of incorporation, matters delegated by the general meeting of shareholders, and important matters related to the Company’s basic management policy and its business execution.
  • The board of directors shall supervise the execution of the duties of the directors
Article 8 (Convocation Request)
  • All directors have the right to request the convocation of the board of directors.
  • The person with the right to convene the board of directors may not refuse or withhold a written request jointly made by at least 1/3 of the total number of directors.
  • In principle, a convocation request shall be made at least two (2) weeks before the date of the meeting. However, for urgent matters, exceptions are made.
Article 9 (Convocation Notice)
  • The notice of convocation of the BOD shall be notified to each director by the secretary of the BOD five (5) days prior to the date of the meeting per the instructions by the chairperson or a director nominated by the chairperson.
    However, in case of urgent matters, the notice may be made one (1) day before the meeting date at the latest.
  • The convocation notice per Paragraph 1 of this Article shall be made to each director in a writing, electronic document, or oral method.
  • With the consent of all the directors, the BOD may be held at any time without the notification procedure stipulated in Paragraph 1 of this Article.
Article 11-3 (BOD Committees)
  • The board of directors may establish the following committees within the board of directors as prescribed by the articles of incorporation for quick and efficient decision-making.
    • 1. Audit Committee
    • 2. Outside Director Candidate Recommendation Committee
    • 3. Internal Transactions Committee
    • 4. Other committees established through the resolution of the BOD
  • The BOD may delegate its authority to a BOD committee, except for the following matters concerning.
    • 1. Proposals requiring approval of the general meeting of shareholders
    • 2. Appointment and dismissal of the CEO
    • 3. Establishment of a BOD committee and the appointment and dismissal of its members
    • 4. Other matters stipulated in the articles of incorporation
  • Details on the composition, authority, operation, etc. of committees within the BOD shall follow the regulations and operating guidelines of each committee. Article 13 (Delegation)
Article 13 (Delegation)

The decision on the following matters is entrusted to the CEO.

  • 1. All matters related to company business that are not specified in Article 11, except for those stipulated by laws or the articles of incorporation
  • 2. Matters entrusted with the decision to the representative director by a resolution of the board of directors
  • 3. Details of the implementation of matters decided by the Board of Directors
Article 16 (Resolution)
  • The resolution of the BOD shall be made with the attendance of a majority of directors and a majority of the directors.
    However, for the resolution of the matters stipulated in Article 11, Item 4, subparagraphs E and H, the attendance of 2/3 of registered directors is required at the minimum.
  • The board of directors may allow all or some of the directors to participate in resolutions by a remote access method that can allow all participants to exchange voices in real-time, instead of attending the meeting in person. In this case, the directors using the remote access method shall be deemed to have attended the board of directors in person.
Article 17 (Voting Rights)
  • Every director has one (1) voting right.
  • Directors shall not exercise their voting right through a proxy.
Article 18 (Limitation of Voting Rights)
  • Directors who have a special interest in the resolution of the BOD shall not exercise their voting right on the relevant matter.
  • Directors unable to exercise their voting rights pursuant to the preceding paragraph shall not be counted in the number of attended directors.
02 Activities of the BOD
2018
2018년 이사회의 주요활동내역 - 회차, 개최일자, 의안내용, 가결여부, 이사성명(박만훈(주1), 안재용, 박찬중, 전광현, 안동현), 출석율, 찬반여부 정보제공
Session Date Agenda Voting Result Director
Man-Hoon Park (Note 1) Jae-Yong Ahn Chan-Joong Park Gwang-Hyun Jeon Dong-Hyun Ahn
Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100%
For / Against
1 Jul. 2, 2018 [Agenda]
  • 1. Appointment of the chairperson of BOD
  • 2. Appointment of the CEO
  • 3. Decision on the location of the head office
  • 4. nstallation of a branch
  • 5. Enactment of executive management regulations
  • 6. Enactment of internal accounting management regulations
  • 7. Appointment of the Fair-Trade Compliance Officer
  • 8. Conclusion of a service contract with SK Chemicals
Pass as drafted For For For For For
2 Nov. 13, 2018 [Agenda]
  • 1. Convocation of an extraordinary general meeting of shareholders
Pass as drafted For For For For For
3 Nov. 13, 2018 [Agenda]
  • 1. Appointment of a transfer agent
  • 2. Issuance of new shares
Pass as drafted For For For For For
4 Dec. 11, 2018 [Agenda]
  • 1. Appointment of the chairperson of BOD
  • 2. Enactment of BOD regulations
  • 3. Convocation of an extraordinary general meeting of shareholders
  • 4. Donation to the University of Alabama at Birmingham
Pass as drafted (Note 1) For For For For

Note 1) Man-Hoon Park, an executive director resigned as of Dec. 9, 2018, and the meetings prior to this resignation were excluded from the report in the calculation of the attendance rate.

2019
2019년 이사회의 주요활동내역 - 회차, 개최일자, 의안내용, 가결여부, 이사성명(안재용, 김훈, 안동현(주2), 박찬중, 전광현), 출석율, 찬반여부 정보제공
Session Date Agenda Voting Result Director
Jae-Yong Ahn Hoon Kim Dong-Hyun Ahn (Note 2) Chan-Joong Park Gwang-Hyun Jeon
Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100%
For / Against
1 Feb. 8, 2019 [Agenda]
  • 1. Approval of financial statements and business reports
Pass as drafted For For For For For
2 Mar. 8, 2019 [Agenda]
  • 1. Convocation of a regular general meeting of shareholders and confirmation of agenda
Pass as drafted For For (Note 2) For For
3 May 30, 2019 [Agenda]
  • 1. Shut down of the Osan branch
Pass as drafted For For (Note 2) For For

Note 2) Dong-Hyun Ahn, a non-executive director resigned as of Mar. 4, 2019, and the meetings prior to this resignation were excluded from the report in the calculation of the attendance rate.

2020
2020년 이사회의 주요활동내역 - 회차, 개최일자, 의안내용, 가결여부, 이사성명(안재용, 김훈, 박찬중, 전광현, 문창진, 조미진, 최정욱), 출석율, 찬반여부 정보제공
Session Date Agenda Voting Result Director
Jae-Yong Ahn Hoon Kim Chan-Joong Park Gwang-Hyun Jeon Chang-Jin Moon Mi-Jin Jo Jeong-Wook Choi
Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100%
For / Against
1 Feb. 6, 2020 [Agenda]
  • 1. Approval of financial statements and business reports
[Report]
  • 1. Report on the operation status of the internal accounting management system
Pass as drafted
 
 
For
 
(Report)
For
 
(Report)
For
 
(Report)
For
 
(Report)
(Note 4) (Note 4) (Note 4)
2 Mar. 9, 2020 [Agenda]
  • 1. Convocation of a regular general meeting of shareholders and confirmation of agenda
  • 2. Revision of executive management regulations
[Report]
  • 1. Report on the 2020 evaluation of internal accounting management system
Pass as drafted
 
 
For
For
 
(Report)
For
For
 
(Report)
For
For
 
(Report)
For
For
 
(Report)
(Note 4) (Note 4) (Note 4)
3 Jul. 22, 2020 [Agenda]
  • 1. Report on major business status
Pass as drafted (Report) (Report) (Report) (Report) (Note 4) (Note 4) (Note 4)
4 Sep. 18, 2020 [Agenda]
  • 1. Closure of the shareholder list and the base day
Pass as drafted For For For For (Note 4) (Note 4) (Note 4)
5 Oct. 5, 2020 [Agenda]
  • 1. Convocation of an extraordinary meeting of shareholders and confirmation of agenda
  • 2. Revision of BOD regulations
  • 3. Capitalization of reserve
Pass as drafted For For For For (Note 4) (Note 4) (Note 4)
6 Oct. 29, 2020 [Agenda]
  • 1. Establishment of an Audit Committee
  • 2. Enactment of Audit Committee regulations
  • 3. Establishment of the Outside Director Candidate Recommendation Committee and appointment of its members
  • 4. Enactment of regulations of the Outside Director Candidate Recommendation Committee
  • 5. Establishment of the Internal Transactions Committee and appointment of its members
  • 6. Enactment of regulations of the Internal Transactions Committee
  • 7. Appointment of the Compliance Officer
  • 8. Enactment of compliance control standards
  • 9. Adjustment of the exercise price and quantity of stock options to free issues and stock splits
Pass as drafted For For (Note 3) (Note 3) For For For
7 Nov. 27, 2020 [Agenda]
  • 1. Resolution of listing on the stock market
  • 2. Approval of revised financial statements
[Report]
  • 1. Report on major business status
Pass as drafted
 
 
For
For
 
(Report)
For
For
 
(Report)
(Note 3) (Note 3) For
For
 
(Report)
For
For
 
(Report)
For
For
 
(Report)
8 Dec. 22, 2020 [BOD Agenda]
  • 1. Revision of internal accounting management regulations
  • 2. Sales of IT assets with SK Chemicals
  • 3. Conclusion of an IT service contract with SK Chemicals
[Report]
  • 1. Report on 2021 business plan
  • 2. Report on some amendments to the Commercial Act
Pass as drafted
 
 
 
For
For
For
 
(Report)
(Report)
For
For
For
 
(Report)
(Report)
(Note 3) (Note 3) For
For
For
 
(Report)
(Report)
For
For
For
 
(Report)
(Report)
For
For
For
 
(Report)
(Report)

Note 3) Gwang-Hyun Jeon and Chan-Joong Park, executive directors, resigned as of Oct. 29, 2020, and the meetings prior to this resignation were excluded from the report in the calculation of the attendance rate.

Note 4) Chang-Jin Moon, Mi-Jin Jo, and Jeong-Wook Choi were appointed as outside directors on Oct. 29, 2020, and the meetings prior to these appointments were excluded from the report in the calculation of the attendance rate.

2021
2021년 이사회의 주요활동내역 - 회차, 개최일자, 의안내용, 가결여부, 이사성명(안재용, 김훈, 권익환, 문창진, 조미진, 최정욱), 출석율, 찬반여부 정보제공
Session Date Agenda Voting Result Director
Jae-Yong Ahn Hoon Kim Ik-Hwan Kwon Chang-Jin Moon Mi-Jin Jo Jeong-Wook Choi
Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100% Attendance 100%
For / Against
1 Jan. 19, 2021 [Report]
  • 1. Report on business status
(Report) (Report) (Report) (Note 5) (Report) (Report) (Report)
2 Jan. 26, 2021 [Report]
  • 1. Report on business status
  • 2. Report on the operation plan of the BOD and BOD committees for Q1 2021
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Note 5)
(Note 5)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
3 Feb. 5, 2021 [Agenda]
  • 1. Approval of the issuance of new shares for listing on the stock market
[Report]
  • 1. Report on business status
Pass as drafted
 
(Report)
For
 
(Report)
For
 
(Report)
(Note 5)
 
(Note 5)
For
 
(Report)
For
 
(Report)
For
 
(Report)
4 Feb. 15, 2021 [Agenda]
  • 1. Approval of financial statements and business reports
[Report]
  • 1. Report on the operation status of the 2020 internal accounting management system
  • 2. Report on the plan to support loans for employee stock ownership
Pass as drafted

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
(Note 5)

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
5 Mar. 8, 2021 [Agenda]
  • 1. Provision of collateral to the employee stock ownership association
Pass as drafted For For (Note 5) For For For
6 Mar. 15, 2021 [Agenda]
  • 1. Convocation of the 3rd regular general meeting of shareholders and confirmation of the meeting agenda
[Report]
  • 1. Report on the IPO progress
  • 2. Report on the 2020 evaluation of internal accounting management system
  • 3. Report on the activities and action plan of the Compliance Officer
Pass as drafted

(Report)
(Report)
(Report)
For

(Report)
(Report)
(Report
For

(Report)
(Report)
(Report
(Note 5)

(Report)
(Report)
(Report)
For

(Report)
(Report)
(Report
For

(Report)
(Report)
(Report
For

(Report)
(Report)
(Report
7 Mar. 31, 2021 [Agenda]
  • 1. Appointment of the CEO​
  • 2. Appointment of the Internal Transactions Committee members​
  • 3. Enactment of the Corporate Governance Charter​
  • 4. Conclusion of ECO LAB lease contract
  • 5. Sub-lease contract and joint operation contract for the Smart Work Center of Kwanhun​
Pass as drafted For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
For
8 Apr. 28, 2021 [Agenda]
  • 1. Sales of IT assets with SK Chemicals
[Report]
  • 1. Report on business performance of Q1 2021​
  • 2. Report on major business status​
Pass as drafted

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
For

(Report)
(Report)
9 May 13, 2021 [Agenda]
  • 1. Land purchase in Andong
Pass as drafted For For For For For For
10 May 26, 2021 [Agenda]
  • 1. Conclusion of a Discovery Lab joint operation contract
  • 2. Establishment of 2021 Safety/Health Plan
  • 3. Approval of 2021 Enterprise KPIs​
Pass as drafted
Pass as drafted
drafted
For
For
Opposition
For
For
Opposition
For
For
Opposition
For
For
Opposition
For
For
Opposition
For
For
Opposition
11 Jun. 24, 2021 [Agenda]
  • 1. Establishment of the Personnel Committee and appointment of its members
  • 2. Enactment of Personnel Committee regulations
  • 3. Establishment of the ESG Committee and appointment of its members
  • 4. Enactment of ESG Committee regulations
  • 5. Reorganization of committees and appointment of members
  • 6. Approval of the introduction of the electronic voting system at the general meeting of shareholders
[Report]
  • 1. Plans to improve the operation of the board of directors and committees​
Pass as drafted
Pass as drafted
Pass as drafted
Pass as drafted
Pass as drafted
Pass as drafted

(Report)
For
For
For
For
For
For

(Report)
For
For
For
For
For
For

(Report)
For
For
For
For
For
For

(Report)
For
For
For
For
For
For

(Report)
For
For
For
For
For
For

(Report)
For
For
For
For
For
For

(Report)
12 Jul. 28, 2021 [Agenda]
  • 1. Conclusion of service contract with SK Chemicals GmbH
  • 2. Subscription to executives’ liability insurance
[Report]
  • 1. Report on business performance of the first half of 2021​
  • 2. Report on 2021 Enterprise KPIs
Pass as drafted
Pass as drafted

(Report)
(Report)
For
For

(Report)
(Report)
For
For

(Report)
(Report)
For
For

(Report)
(Report)
For
For

(Report)
(Report)
For
For

(Report)
(Report)
For
For

(Report)
(Report)
13 Aug. 25, 2021 [Agenda]
  • 1. Approval of 2021 Enterprise KPIs
  • 2. Site purchase contract for Global R&PD Center
[Report]
  • 1. Report on the Global R&PD Center construction plan​
Pass as drafted
Pass as drafted

(Report)
For
For

(Report)
For
For

(Report)
For
For

(Report)
For
For

(Report)
For
For

(Report)
For
For

(Report)
14 Sept. 23, 2021 [Report]
  • 1. Report on the executive personnel management system
  • 1. Report on the global bio ecosystem development plan (draft)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
15 Oct. 27, 2021 [Agenda]
  • 1. Signing of a sponsorship agreement with Foundation Academia Platonica
[Report]
  • 1. Report on business performance in Q3 2021​
Pass as drafted

(Report)
For

(Report)
For

(Report)
For

(Report)
For

(Report)
For

(Report)
For

(Report)
16 Nov. 30, 2021 [Report]
  • 1. Report on the progress of Project Rhapsody​
  • 2. Report on the organizational restructuring and executive personnel plan for 2022 (draft)​
  • 3. CEO evaluations
  • 4. Review of CEO retention​
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)
(Report)

Note 5) Ik-Hwan Kwon, the outside director was appointed as of Mar. 31, 2021, and the meetings prior to this appointment were excluded from the report in the calculation of attendance rate.

03 Activities of outside directors at the BOD
이사회에서의 사외이사의 주요활동내역- 회차, 개최일자, 사외이사 참석인원, 비고 정보제공
Session Date outside directors Members Remarks
6 2020.10.29 3(3) -
7 2020.11.27 3(3) -
8 2020.12.22 3(3) -
1 2021.01.19 3(3) -
2 2021.01.26 3(3) -
3 2021.02.05 3(3) -
4 2021.02.15 3(3) -
5 2021.03.08 3(3) -
6 2021.03.15 3(3) -
7 2021.03.31 4(4) -
8 2021.04.28 4(4) -
9 2021.05.13 4(4) -
10 2021.05.26 4(4) -
11 2021.06.24 4(4) -
12 2021.07.28 4(4) -
13 2021.08.25 4(4) -
14 2021.09.23 4(4) -
15 2021.10.27 4(4) -
16 2021.11.30 4(4) -